TickerFacts.

Spero Therapeutics, Inc. (SPRO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$86.03M
Year ended 2020-12-31
2015-12-31: -$9.84M2016-12-31: -$29.79M2017-12-31: -$39.14M2018-12-31: -$42.06M2019-12-31: -$50.33M2020-12-31: -$86.03M-$86.03M
2015-12-31 Free Cash Flow (USD) 2020-12-31
Period endedFree Cash FlowChange YoYSource filing
2020-12-31-$86.03Mn/m2022-03-31, From 2020-01-01
2019-12-31-$50.33Mn/m2021-03-11, From 2019-01-01
2018-12-31-$42.06Mn/m2020-03-16, From 2018-01-01
2017-12-31-$39.14Mn/m2019-03-14, From 2017-01-01
2016-12-31-$29.79Mn/m2019-03-14, From 2016-01-01
2015-12-31-$9.84Mn/a2018-04-02, From 2015-01-01